A lump or sore that doesn't heal
In the mouth, on the lip, or a painless lump in the neck.
Head and neck cancers — including nasopharyngeal cancer, one of the more common cancers in Singapore — sit amongst the structures that let you speak, swallow and taste. Radiotherapy is central to their cure, and modern precision techniques exist to protect exactly those functions.
Most head and neck cancers arise from squamous cells — the cells lining the moist inner surfaces of the mouth, nose and throat — and are called squamous cell carcinomas. The salivary glands contain different cell types and can develop rarer tumours of their own.
The category covers cancers of the mouth, tongue, lips, soft palate, nasal and paranasal sinuses, nasopharynx, throat, tonsils, salivary glands and thyroid. In Singapore, nasopharyngeal cancer (NPC) is one of the more common cancers — and one where radiotherapy is the primary curative treatment.
Each type carries a different prognosis and treatment plan — which is why precise diagnosis of the exact site and stage comes before any treatment decision.
Symptoms depend on the exact site — but these general signs, when persistent, warrant assessment:
In the mouth, on the lip, or a painless lump in the neck.
A sore throat that doesn't resolve with usual treatment.
Food sticking, pain on swallowing, or progressive difficulty.
Hoarseness or a change in the voice that persists beyond a few weeks.
White or red patches on the gums, tongue or mouth lining; jaw swelling; unusual bleeding or pain.
One-sided blocked ear, hearing change, or blood-stained nasal discharge — classic NPC warning signs.
Diagnosis maps the exact site, extent and type — the three things that determine whether surgery, radiation or both lead the plan.
A specialist examination of the mouth, nose and throat, including flexible nasoendoscopy to visualise the nasopharynx and larynx.
Tissue from the suspicious site — or a needle sample from a neck lump — confirms the cancer type.
Detailed imaging maps the tumour's local extent and relationship to critical structures.
Whole-body imaging checks lymph nodes and distant sites, completing the stage.
Tobacco and alcohol drive most head and neck cancers worldwide — with two additional factors especially relevant in Asia:
Smoking and chewed tobacco are the dominant risk factors for oral and throat cancers.
Heavy alcohol use multiplies tobacco's risk rather than merely adding to it.
EBV is strongly associated with nasopharyngeal cancer — part of why NPC is more common in this region.
Human papillomavirus drives a growing share of tonsil and tongue-base cancers.
Family history of NPC raises risk, particularly in southern Chinese populations.
Diets high in salt-preserved fish and foods are associated with NPC risk.
Radiotherapy is central to head and neck cancer treatment — often curative on its own for NPC, or combined with chemotherapy and surgery for other sites. Precision here is not cosmetic: it protects your voice, swallowing and salivary function.
Intensity-modulated radiation sculpts dose around the salivary glands, swallowing muscles and spinal cord — the standard of care for head & neck sites.
Radiation with concurrent chemotherapy for locally advanced disease — the curative backbone for NPC and many throat cancers.
Daily imaging keeps millimetre accuracy through a 6–7 week course, even as anatomy changes.
Stereotactic techniques for selected skull-base tumours and re-irradiation of recurrent disease.
Every plan at AARO goes through detailed contouring, dose simulation, and independent physics review before a single beam is delivered. We do this so the radiation hits exactly the tissue that needs it — and avoids the healthy tissue around it.
Our medical physicists and radiation therapists collaborate on each plan — contouring tumour and organs-at-risk, simulating dose distribution, and independently checking every parameter before delivery.
Imaging before each fraction confirms the target's position to the millimetre — so tight margins stay safe, and healthy tissue stays out of the high-dose region.
Each treatment session takes 15–30 minutes. You'll lie on a precision treatment couch beneath the linear accelerator. Positioning lasers and daily imaging align you to within a millimetre of the planned position.
You won't feel the radiation as it's delivered. There's no anaesthesia, no recovery time, and no overnight stay. Most patients drive themselves home after the session and return to normal activities the same day.
Head and neck radiotherapy at AARO is led by sub-specialists in nasopharyngeal, oral and throat cancers, working jointly with your ENT surgeon and medical oncologist.
Book a 45–60 minute specialist consultation. We'll review your imaging and pathology, explain the options that apply to your case, and answer your questions.